UNSPSC 51472002: Glutaraldehyde

This classification denotes an industrial aid with the molecular formula C5H8O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier T3C89M417N, chemically known as 1,5-pentanedione but generally known as glutaral, which bears US NIH Compound Identifier 3485. European Medicines Agency schedules Glutaral in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07943MIG. The term GLUTARAL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 27, No. 10 1973, List 13).

GLUTARAL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. SMILES: C(CC=O)CC=O.

UNSPSC 51472002 Glutaraldehyde is a Commodity code purchasing a high-level disinfectant and sterilizing agent used across state and local public facilities, particularly in healthcare, fire rescue operations, and institutional settings where infection control and equipment sterilization are critical. State and local governments procure glutaraldehyde as part of broader janitorial, operational, and pharmaceutical supply contracts serving multiple departments and facilities simultaneously; it appears as a line item within larger consumables agreements rather than as a standalone product solicitation.

Issuing bodies under this code span county governments and multistate cooperative purchasing alliances. Hillsborough County Board of County Commissioners and the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, represent recent active buyers. Recent opportunities show glutaraldehyde appearing within two distinct procurement contexts: Hillsborough County's Janitorial and Operational Supplies ITB (ITB2600319, due July 24, 2026) for the Hillsborough County Fire Rescue Department, with an estimated one-year contract value of $765,679.84 and delivery requirements to the Public Safety Operations Complex in Tampa, Florida; and MMCAP's Generic Multi-Source Pharmaceuticals and OTC Products RFP (S1070000015802, due March 26, 2026) establishing multiple vendor contracts distributed across Minnesota and Oregon state and local government healthcare facilities, with products effective July 1, 2026. Geographic activity concentrates in Florida and the Upper Midwest (Minnesota and Oregon), with MMCAP contracts available to participating state and local members under the same terms. Both opportunities require vendors to be authorized distributors with capability for backorder management, chain of custody tracking, and compliance with FDA and manufacturing standards including cGMP certification and the Drug Supply Chain Security Act.